Executive Director, Global Business Development, Transactions

At Daiichi Sankyo, we are united by a single purpose, to improve lives around the world through innovative medicines. With a legacy of innovation since 1899, a presence in more than 30 countries, and more than 19,000 employees, we are advancing breakthrough therapies in oncology, cardiovascular disease, rare diseases, and immune disorders. Guided by our 2030 vision to "be an innovative global healthcare company contributing to the sustainable development of society", we are shaping a healthier, more hopeful future for patients, their families, and society.

Job SummaryThe candidate for Executive Director, Global Business Development – Transactions will possess a strong business acumen with extensive experience in the life sciences and biopharmaceutical industry particularly in the area of Oncology. Expertise and prior experience in the deal making process in the industry as evidenced by a comprehensive deal sheet indicating prior successful deal leadership to closing across the range of counterparties/collaboration partners typically encountered by the Daiichi Sankyo Transactions team is required. The candidate will lead efforts in partnering/licensing for research, development, and commercialization of therapies with a particular focus in Oncology. The candidate is required to have strong interpersonal skills and work with a multitude of internal/external stakeholders to facilitate highly visible and time-sensitive business development projects. The purpose of this job is to identify, coordinate the assessment of, and help secure pipeline- and portfolio-enhancing, business opportunities (through licensing, acquisition, co-promotion, and other structures.). This role is a primary business development transaction lead for the Oncology Business Unit (OBU)/R&D, and is responsible for overseeing business development opportunities across a range of categories designed to advance the existing pipeline (including strategic collaborations with pharma partners, companion diagnostic deals, combination studies, ARO collaborations, platform licensing, co-development agreements, divestitures and others) as well as to acquire new product opportunities to augment our pipeline. This role is responsible for interacting with senior leadership within R&D as well as CEOs, heads of R&D, etc. as well as at companies with whom we are potentially doing a deal. In leading deal teams, this person is responsible for coordinating with commercial, R&D, legal, intellectual property, finance, supply chain, and other relevant functional area colleagues, at all levels, and across geographies, and is required to lead the diligence and assessment process and take lead responsibility for pulling together a recommendation for presentation to senior management. Externally, the job requires initial meetings with potential partners; coordination of capability presentations; coordination of diligence meetings; leading negotiation sessions; and alliance management participation during and following successful completion of business arrangements. This role also requires one to supervise, train and develop other business development professionals within the Global Business Development function.ResponsibilitiesExecute assigned transactions through proposal/review/negotiation of NBTS and Definitive Agreements, acting as Lead for many opportunities as assigned by the Vice President Global Business Development
Work in concert with key Functional Area Leads (esp. R&D Finance, R&D (Global Project Team Leader), Business Development, Legal and others) and Senior Management Global Business Development/Daiichi Sankyo Corporate in Tokyo to secure alignment on key terms and conditions prior to and during active negotiations.
Communicate activities frequently across the organization through related internal approval committees
Communications should include sharing of key contract related terms and conditions to key internal stakeholders as well as the related strategic, financial, scientific and commercial rationale for each opportunity reflecting internal analyses as well as diligence activities.
Respond to Q&A from Corporate Finance, Tokyo Business Development, Oncology Business Global Oncology Marketing, OBU, R&D, Corporate Business Management, Senior Management, and other key stakeholders as indicated. Meet with other pharmaceutical company licensing groups, participate in industry meetings, conduct proactive product searches, and coordinate search efforts to identify new opportunities to enhance the pipeline as well as in line products. Together with colleagues from Search and Evaluation, coordinate with commercial, R&D, finance, supply chain, intellectual property, legal, etc., on both preliminary and full assessments of potential opportunities, and summarize conclusions and recommendations for discussion with and presentation to senior management.
Schedule and lead diligence meetings with potential partners. Provide strategic alliance management for deals to monitor compliance, resolve strategic issues and re-negotiate, if necessary Assure functional excellence by training and development of more junior staff and Direct Report(s).Responsibilities ContinuedQualifications Education Qualifications
MBA A strong finance focus is preferred. preferred or Master's Degree Consider a Master in Engineering Management or a Master's of Finance with relevant experience. preferred PhD preferred MD preferred JD JD is also acceptable if accompanied by proven expertise in leadership of large transactions. Bachelor's Degree required

Experience Qualifications
Must have 10+ years of experience within the pharmaceutical industry. Previous Big Pharma experience required. required
in leading complex negotiations in a variety of Oncology focused transactions (including multiple major or complex transactions) to closing required
Proven ability to manage teams and coach team members’ career development. Track record of training and mentoring junior staff. preferred
Matrix experience preferred.
Branded Oncology transactions experience required
Proven financial expertise along with a strong track record of independently leading transactions within oncology. A deal sheet will be required.
Companion Diagnostic contracting expertise strongly preferred.
Expertise in leading contract negotiations and closing complex, oncology deals required.
Proven professional transaction experience should include the leadership of, complex Co-development/ Co-commercialization agreements, joint ventures, as well as clinical trial agreements, material transfer agreements, and divestitures, in/out-licensing, acquisitions, academic research agreements and venture capital investments. required
Demonstrate ability to work independently and influence other key business stakeholders both internally and externally. required
10+ years of demonstrated proficiency leading complex negotiations in a variety of Oncology focused transactions (including multiple major or complex transactions) to closing. required
Deal sheet reflecting breadth of transaction leadership/success required

Travel Requirements
Ability to travel up to 30% of the time. Frequent overnight travel as required by the deal process; domestic; some global

Additional Information

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.

Salary Range:

USD$255,000.00 - USD$425,000.00